Skip to main content
Gubra A/S logo

Gubra A/S — Investor Relations & Filings

Listed
Ticker · GUBRA ISIN · DK0062266474 LEI · 254900T17RRFZONO6W53 CO Professional, scientific and technical activities
Open in API
Filings indexed 95 across all filing types
Latest filing 2026-06-17 Director's Dealing
Country DK Denmark
Listing CO GUBRA · 8 venues

About Gubra A/S

https://www.gubra.dk/

Gubra A/S is a biotechnology company and preclinical Contract Research Organization (CRO) specializing in peptide-based drug discovery. The company operates a dual business model, providing preclinical research services to pharmaceutical and biotech clients while also developing its own proprietary pipeline of therapeutics. Gubra's primary focus is on metabolic diseases, such as obesity, diabetes, and MASH (metabolic dysfunction-associated steatohepatitis), as well as fibrotic diseases. Its research and development activities also extend into inflammatory conditions, CNS, respiratory, and women's health. The CRO services division supports clients in advancing their drug development programs through expertise in areas like in vivo pharmacology and peptide chemistry.

Recent filings

Filing Released Lang Actions
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Director's Dealing Classification · 100% confidence The document is a regulatory press release reporting transactions made by a person discharging managerial responsibilities (Chief Financial Officer) in the company's shares. It details an acquisition of shares as part of an Employee Share Purchase Plan, including share volume, price, date, and place of transaction. This fits precisely the description of a Director's Dealing report, which records personal share transactions by company directors and executives. The text is a notification consistent with insider trading reporting requirements under the Market Abuse Regulation. There is no financial report, earnings announcement, or other categories applicable. Therefore, the correct classification is Director's Dealing (DIRS).
2026-06-17 English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Director's Dealing Classification · 100% confidence The document is a regulatory press release dated 17 June 2026 reporting a transaction made by a person discharging managerial responsibilities (CEO Markus Rohrwild) acquiring shares in the company Gubra A/S under an Employee Share Purchase Plan. It involves detailed disclosure of a director's personal share transaction pursuant to Market Abuse Regulation article 19. The content describes insider trading by a senior management person and does not present financial results, reports, or corporate governance changes, but rather insider share dealings. Therefore, the best classification for this document is Director's Dealing (DIRS). The document length is relatively short and focused solely on this insider transaction disclosure.
2026-06-17 English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Director's Dealing Classification · 92% confidence The document is a regulatory press release disclosing transactions by a person discharging managerial responsibilities (the CFO) in the company’s shares pursuant to the Market Abuse Regulation article 19. This is a classic insider/ director dealing notification rather than a financial report, presentation, or other filing type.
2026-06-10 English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Financial Supplement Data Classification · 100% confidence
2026-06-10 English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Director's Dealing Classification · 95% confidence The document is a regulatory press release disclosing insider transactions by a person discharging managerial responsibilities (CFO) under the Market Abuse Regulation. It details the exercise of warrants, volumes, prices, and dates for shares by a company director. This matches the ‘Director's Dealing’ category (insider trades).
2026-06-10 English
Gubra capital increase in connection with exercise of warrants
Share Issue/Capital Change Classification · 90% confidence The document is a regulatory press release announcing a capital increase through the exercise of warrants, detailing the number of new shares, subscription price, total proceeds, and updated share capital. This is a clear announcement of a share issue/capital change rather than an actual financial report or other filing. Accordingly, it fits the ‘Share Issue/Capital Change’ category.
2026-06-08 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.